2020
DOI: 10.1111/jce.14725
|View full text |Cite
|
Sign up to set email alerts
|

First interventional exchange of a left transvenous phrenic nerve stimulation lead from the novel remedē system

Abstract: The remedē system is a novel fully implantable transvenous phrenic nerve stimulation (TPNS) device developed to treat central sleep apnea. No information is published on how to explant or replace its leads. An eighty‐one year‐old had a fractured lead and we removed it over a wire. However, unbreachable resistances occurred with a new lead deployed over the enclosed wire and interventional endovascular techniques were performed to reimplant a new fully functioning system. This first report demonstrates TPNS lea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
4

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 15 publications
0
0
0
1
Order By: Relevance
“…Abschn. 3.4.3), und die alleinige Betrachtung von Surrogatparametern erscheint nach den Ergebnissen der SERVE-HF-Studie nicht mehr adäquat [ 70 , 71 ].…”
Section: Schlafbezogene Atmungsstörungenunclassified
“…Abschn. 3.4.3), und die alleinige Betrachtung von Surrogatparametern erscheint nach den Ergebnissen der SERVE-HF-Studie nicht mehr adäquat [ 70 , 71 ].…”
Section: Schlafbezogene Atmungsstörungenunclassified